The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid β fibril formation

Point mutations in the amyloid precursor protein gene (APP) cause familial Alzheimer's disease (AD) by increasing generation or altering conformation of amyloid beta (A beta). Here, we describe the Uppsala APP mutation (Delta 690-695), the first reported deletion causing autosomal dominant AD....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science translational medicine 2021-08, Vol.13 (606), p.1, Article 6184
Hauptverfasser: de la Vega, Maria Pagnon, Giedraitis, Vilmantas, Michno, Wojciech, Kilander, Lena, Guener, Goekhan, Zielinski, Mara, Lowenmark, Malin, Brundin, RoseMarie, Danfors, Torsten, Soderberg, Linda, Alafuzoff, Irina, Nilsson, Lars N. G., Erlandsson, Anna, Willbold, Dieter, Mueller, Stephan A., Schroeder, Gunnar F., Hanrieder, Jorg, Lichtenthaler, Stefan F., Lannfelt, Lars, Sehlin, Dag, Ingelsson, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Point mutations in the amyloid precursor protein gene (APP) cause familial Alzheimer's disease (AD) by increasing generation or altering conformation of amyloid beta (A beta). Here, we describe the Uppsala APP mutation (Delta 690-695), the first reported deletion causing autosomal dominant AD. Affected individuals have an age at symptom onset in their early forties and suffer from a rapidly progressing disease course. Symptoms and biomarkers are typical of AD, with the exception of normal cerebrospinal fluid (CSF) A beta 42 and only slightly pathological amyloid-positron emission tomography signals. Mass spectrometry and Western blot analyses of patient CSF and media from experimental cell cultures indicate that the Uppsala APP mutation alters APP processing by increasing beta-secretase cleavage and affecting alpha-secretase cleavage. Furthermore, in vitro aggregation studies and analyses of patient brain tissue samples indicate that the longer form of mutated A beta, A beta Upp1-42(Delta 19-24), accelerates the formation of fibrils with unique polymorphs and their deposition into amyloid plaques in the affected brain.
ISSN:1946-6234
1946-6242
1946-6242
1946-3242
DOI:10.1126/scitranslmed.abc6184